- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 403/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 403/06
Total number of patents in this class: 3308
10-year publication summary
|
280
|
251
|
215
|
252
|
265
|
219
|
185
|
225
|
210
|
49
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7958 |
72 |
| Novartis AG | 11238 |
48 |
| Boehringer Ingelheim International GmbH | 4629 |
48 |
| Takeda Pharmaceutical Company Limited | 2961 |
46 |
| Merck Sharp & Dohme LLC | 3689 |
43 |
| Bristol-myers Squibb Company | 5080 |
41 |
| VALO Health, Inc. | 147 |
39 |
| Janssen Pharmaceutica N.V. | 3839 |
37 |
| LG Chem, Ltd. | 17205 |
36 |
| Hoffmann-La Roche Inc. | 3060 |
35 |
| Achillion Pharmaceuticals, Inc. | 176 |
34 |
| Bayer Pharma AG | 1096 |
32 |
| Merck Patent GmbH | 5909 |
29 |
| Cancer Research Technology Limited | 542 |
26 |
| Astex Therapeutics Limited | 267 |
23 |
| Schering Corporation | 557 |
22 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
22 |
| Mindset Pharma Inc. | 39 |
20 |
| AstraZeneca AB | 3042 |
17 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
17 |
| Other owners | 2621 |